283 related articles for article (PubMed ID: 11122013)
1. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction.
Oyama N; Iwatsuki K; Satoh M; Akiba H; Kaneko F
Br J Dermatol; 2000 Dec; 143(6):1140-8. PubMed ID: 11122013
[TBL] [Abstract][Full Text] [Related]
2. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
[TBL] [Abstract][Full Text] [Related]
3. 1 alpha,25-dihydroxyvitamin D3 increases TGF beta 1 binding to human osteoblasts.
Nagel D; Kumar R
Biochem Biophys Res Commun; 2002 Feb; 290(5):1558-63. PubMed ID: 11820800
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
Saed GM; Collins KL; Diamond MP
Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
[TBL] [Abstract][Full Text] [Related]
6. The expression of transforming growth factor-beta by cultured chick growth plate chondrocytes: differential regulation by 1,25-dihydroxyvitamin D3.
Farquharson C; Law AS; Seawright E; Burt DW; Whitehead CC
J Endocrinol; 1996 May; 149(2):277-85. PubMed ID: 8708539
[TBL] [Abstract][Full Text] [Related]
7. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta isoforms in renal fibrogenesis.
Yu L; Border WA; Huang Y; Noble NA
Kidney Int; 2003 Sep; 64(3):844-56. PubMed ID: 12911534
[TBL] [Abstract][Full Text] [Related]
9. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts.
Ghahary A; Shen Q; Shen YJ; Scott PG; Tredget EE
J Cell Physiol; 1998 Mar; 174(3):301-9. PubMed ID: 9462692
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta is not involved in early phase growth inhibition of keratinocytes by 1alpha,25(OH)2vitamin D3.
Shirakata Y; Ueno H; Hanakawa Y; Kameda K; Yamasaki K; Tokumaru S; Yahata Y; Tohyama M; Sayama K; Hashimoto K
J Dermatol Sci; 2004 Oct; 36(1):41-50. PubMed ID: 15488704
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD
J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676
[TBL] [Abstract][Full Text] [Related]
12. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells.
Wu Y; Haugen JD; Zinsmeister AR; Kumar R
Biochem Biophys Res Commun; 1997 Oct; 239(3):734-9. PubMed ID: 9367838
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Koli K; Keski-Oja J
Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts.
Wen FQ; Kohyama T; Sköld CM; Zhu YK; Liu X; Romberger DJ; Stoner J; Rennard SI
Inflammation; 2003 Feb; 27(1):9-19. PubMed ID: 12772773
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
18. Fetal and adult fibroblasts have similar TGF-beta-mediated, Smad-dependent signaling pathways.
Colwell AS; Krummel TM; Longaker MT; Lorenz HP
Plast Reconstr Surg; 2006 Jun; 117(7):2277-83. PubMed ID: 16772929
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 stimulates transforming growth factor-beta1 synthesis by mouse renal proximal tubular cells.
Weinreich T; Landolt M; Booy C; Wüthrich R; Binswanger U
Kidney Blood Press Res; 1999; 22(3):99-105. PubMed ID: 10394107
[TBL] [Abstract][Full Text] [Related]
20. Keratinocytes suppress transforming growth factor-beta1 expression by fibroblasts in cultured skin substitutes.
Le Poole IC; Boyce ST
Br J Dermatol; 1999 Mar; 140(3):409-16. PubMed ID: 10233258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
